Absence of PMS2 mutations in colon-CFR participants whose colorectal cancers demonstrate unexplained loss of MLH1 expression

M Clendenning; F Macrae; M Walsh; RJ Walters; SN Thibodeau; SR Gunawardena; JD Potter; RW Haile; S Gallinger; JL Hopper; MA Jenkins; C Rosty; JP Young; DD Buchanan

Journal article

Absence of PMS2 mutations in colon-CFR participants whose colorectal cancers demonstrate unexplained loss of MLH1 expression

M Clendenning, F Macrae, M Walsh, RJ Walters, SN Thibodeau, SR Gunawardena, JD Potter, RW Haile, S Gallinger, JL Hopper, MA Jenkins, C Rosty, JP Young, DD Buchanan

Clinical Genetics | WILEY-BLACKWELL | Published : 2013

DOI: 10.1111/cge.12011

University of Melbourne Researchers

Mark Clendenning Author

Finlay Macrae Author

John Hopper Author

Mark Jenkins Author

Related Projects (2)

COMPREHENISVE MODEL FOR COLORECTAL CANCER RISK

I am a genetic epidemiologist focused on bowel cancer risk. I will develop a comprehensive model to estimate individual cancer risk by study..

CANCER FAMILY REGISTRIES FOR COLORECTAL CANCER (COLON CFRS)

DESCRIPTION (provided by applicant): The Colon Cancer Family Registry - Australasia (CCFR-A) has made an important and substantial contribut..

Grants

Awarded by National Cancer Institute

Citation metrics

8Scopus

7Web of Science

8Dimensions

Keywords

3202 Clinical Sciences

31 Biological Sciences

32 Biomedical and Clinical Sciences

Cancer

Genetics

Rare Diseases

Life Sciences & Biomedicine

Colorectal Cancer Family Registry

3105 Genetics

Women'S Health

Lynch-Syndrome